“There was no difference in prostate cancer mortality at 15 years between the groups,” says NYU Langone’s Stacy Loeb. “That’s also very good news.” Read More
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.